KARACHI: Liven Pharma Limited announced its first successful export to the Arab region on Thursday, according to a notice issued to the Pakistan Stock Exchange (PSX).
The order, which was received last year, has been completed in the current year.
In addition, the company disclosed plans to raise Rs200 million through a rights issue to strengthen its financial position and support business expansion.
Liven Pharma will issue 20 million ordinary shares at Rs10 per share, representing around 21.5% of its existing paid-up capital. This translates to 21.496 rights shares for every 100 ordinary shares held by shareholders at the close of the share transfer books.
Liven Pharma was incorporated as a private limited company in Pakistan on October 21, 1991, and converted into a public limited company on April 30, 1992. The company is engaged in the manufacturing of pharmaceuticals and allied products.
Discover more from Brackly News
Subscribe to get the latest posts sent to your email.
